Evidera
Irina Proskorovsky has extensive work experience in the field of statistics, primarily within the pharmaceutical and biostatistics industry. Irina is currently the Executive Director of Statistics at EVIDERA, INC., a position they have held since January 2023. Prior to this role, they worked at Evidera where they held several positions including Senior Director, Senior Research Leader starting in April 2019, Director, Principal Statistician from April 2016 to January 2023, and Senior Statistician from July 2013 to March 2016. Before joining Evidera, Irina worked as a Senior Biostatistician at UBC - An Express Scripts Company from 2007 to 2013. Irina began their career as a Biostatistician at Caro Research, where they worked from 2002 to 2007.
Irina Proskorovsky pursued their Master of Science (M.Sc.) in Biostatistics at McGill University from 2006 to 2008.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.